Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
As of: Oct 21, 2026 · 1:53 PM EDT

Grace Therapeutics (GRCE) Other Non-Current Assets (2018 - 2020)

Updated

Grace Therapeutics (GRCE) reported Other Non-Current Assets of $691,000 for fiscal Q1 2021 (quarter ended Jun 30, 2020), up 46.1% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Other Non-Current Assets (2018 - 2020) Analysis & Trends

At the end of FY2020 (ended Mar 31, 2020), Grace Therapeutics posted Other Non-Current Assets of $473,000, up 1.5% from FY2019.

  • By fiscal year, Other Non-Current Assets came in at $466,000 in FY2019 (-10.6%) and $521,404 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn 14.27 Bn
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn 10.73 Bn
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn -
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn 4.75 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 9.94 Bn
10 Grace Therapeutics 34.02 Mn -32.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 883,000.00
Mar 31, 2020 473,000.00
Mar 31, 2019 877,852.62
Mar 31, 2018 942,034.65
API Access

Grace Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY